Journal
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
Volume 116, Issue -, Pages 1-20Publisher
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.neubiorev.2020.06.010
Keywords
Zebrafish; Epilepsy; Pharmacological models; Gene; EEG; High-throughput screening
Categories
Funding
- European Union [798703-GEMZ-H2020-MSCA-IF-2017]
- ERA-NET [284365]
- MSCA-COFUND-FP scheme (EU) [801133]
- MechEPI (Mechanisms of Epileptogenesis) [INTER/DFG/17/11583046]
Ask authors/readers for more resources
Zebrafish are now widely accepted as a valuable animal model for a number of different central nervous system (CNS) diseases. They are suitable both for elucidating the origin of these disorders and the sequence of events culminating in their onset, and for use as a high-throughput in vivo drug screening platform. The availability of powerful and effective techniques for genome manipulation allows the rapid modelling of different genetic epilepsies and of conditions with seizures as a core symptom. With this review, we seek to summarize the current knowledge about existing epilepsy/seizures models in zebrafish (both pharmacological and genetic) and compare them with equivalent rodent and human studies. New findings obtained from the zebrafish models are highlighted. We believe that this comprehensive review will highlight the value of zebrafish as a model for investigating different aspects of epilepsy and will help researchers to use these models to their full extent.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available